TRANSCODE THERAPEUTICS INC (RNAZ) Stock Balance Sheet
NASDAQ:RNAZ - Nasdaq - US89357L4023 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 9.00K | N/A | |||
| Cash Equivalents | 11.57M | 5.81M | 2.77M | 4.97M | 20.83M | |||
| Receivables | 322.40K | N/A | N/A | 360.00K | N/A | |||
| Other Current Assets | 1.15M | 1.28M | 1.69M | 2.04M | 1.91M | |||
| Total Current Assets | 13.04M | 7.09M | 4.46M | 7.38M | 22.73M | |||
| Non-Current Assets | ||||||||
| PPE Net | 38.10K | 89.30K | 602.00K | 209.00K | 206.00K | |||
| Other Non-Current Assets | 111.90K | 111.90K | 112.00K | N/A | 0.00 | |||
| Total Non-Current Assets | 150.00K | 201.20K | 715.00K | 209.00K | 206.00K | |||
| TOTAL ASSETS | 13.19M | 7.29M | 5.17M | 7.59M | 22.94M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.01M | 1.45M | 1.51M | 923.00K | N/A | |||
| Accounts Payable | 1.50M | 1.29M | 1.96M | 3.42M | 2.50M | |||
| Other Current Liabilities | 0.00 | 25.40K | 27.00K | 0.00 | 31.00K | |||
| Total Current Liabilities | 2.51M | 2.77M | 3.49M | 4.35M | 2.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 392.00K | 6.54M | 38.00K | N/A | 0.00 | |||
| Total Non-Current Liabilities | 392.00K | 6.54M | 38.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 2.90M | 9.31M | 3.53M | 4.35M | 2.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -75.29M | -63.20M | -46.42M | -27.87M | -10.30M | |||
| Additional Paid In Capital | 85.58M | 61.18M | 48.06M | 31.11M | 30.71M | |||
| Common Shares | 2.30K | 100.00 | 0.00 | 1.00K | 1.00K | |||
| Shares Outstanding | 833.60K | 36.80K | 627.00K | 16.00K | 16.00K | |||
| Tangible Book Value per Share | 12.35 | -54.93 | 2.62 | 202.56 | 1.28K | |||
| Total Shareholders' Equity | 10.29M | -2.02M | 1.64M | 3.24M | 20.40M | |||
| TOTAL LIABILITIES AND EQUITY | 13.19M | 7.29M | 5.17M | 7.59M | 22.94M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.20 | 2.56 | 1.28 | 1.70 | 8.97 | |||
| Return On Assets (ROA) | -193.60% | -230.11% | -358.73% | -231.48% | -29.83% | |||
| Return On Equity (ROE) | -248.18% | N/A | -1130.17% | -541.96% | -33.54% | |||
All data in USD , ROIC based on taxRate of 0.21